Growth Metrics

Astria Therapeutics (ATXS) Other Non Operating Income: 2017-2018

Historic Other Non Operating Income for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to -$145,000.

  • Astria Therapeutics' Other Non Operating Income fell 1135.71% to -$145,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $176,000, marking a year-over-year increase of 450.00%. This contributed to the annual value of $176,000 for FY2018, which is 450.00% up from last year.
  • According to the latest figures from Q4 2018, Astria Therapeutics' Other Non Operating Income is -$145,000, which was down 189.51% from $162,000 recorded in Q3 2018.
  • In the past 5 years, Astria Therapeutics' Other Non Operating Income registered a high of $162,000 during Q3 2018, and its lowest value of -$145,000 during Q4 2018.
  • Moreover, its 2-year median value for Other Non Operating Income was $13,000 (2017), whereas its average is $26,000.
  • Over the last 5 years, Astria Therapeutics' Other Non Operating Income had its largest YoY gain of 3,340.00% in 2018, and its largest YoY loss of 1,135.71% in 2018.
  • Quarterly analysis of 2 years shows Astria Therapeutics' Other Non Operating Income stood at $14,000 in 2017, then crashed by 1,135.71% to -$145,000 in 2018.
  • Its Other Non Operating Income was -$145,000 in Q4 2018, compared to $162,000 in Q3 2018 and $147,000 in Q2 2018.